Abstract
Perioperative hypotension has been recognized as a major risk factor for spinal cord ischemia (SCI) in patients undergoing thoracic endovascular aortic repair (TEVAR). Multiple studies have supported the importance of hemodynamic augmentation to reduce the risk of SCI in this high-risk patient population. However, prophylactic postoperative vasopressor administration in TEVAR patients could yield deleterious consequences. In our study, we aimed to determine the association between prophylactic postoperative vasopressor use and 30-day mortality after TEVAR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
